AHR and cancer: Tumor-released kynurenine activates AHR in megakaryocytic-erythroid progenitor cells, driving their differentiation toward megakaryocytes by inducing Runt-related transcription factor 1.434 This AHR-dependent mechanism contributes to the elevated platelet counts and reduced red blood cell counts observed in cancer.